Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × Methylene Blue × Clear all

Phase

Phase NA 6 Phase 2 3 Phase EARLY_PHASE1 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Shock, Septic 1

Interventions

Cisplatin 53 Cyclophosphamide 42 Fluorouracil 41 Oxaliplatin 36 Capecitabine 35 Docetaxel 34 Drug Therapy 32 Radiotherapy 31 Gemcitabine 30 Paclitaxel 25 Carboplatin 23 Dexamethasone 22 Leucovorin 21 Etoposide 17 Doxorubicin 17 Cytarabine 17 apatinib 16 Methotrexate 16 Radiation 13 Magnetic Resonance Spectroscopy 13 Epirubicin 13 Busulfan 13 Surgical Procedures, Operative 12 Neoadjuvant Therapy 12 Letrozole 12 Decitabine 12 Bevacizumab 12 Saline Solution 11 venetoclax 10 fludarabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡